Double somatic SMARCB1 and NF2 mutations in sporadic spinal schwannoma

被引:9
作者
Paganini, Irene [1 ]
Capone, Gabriele Lorenzo [1 ]
Vitte, Jeremie [2 ,3 ]
Sestini, Roberta [1 ]
Putignano, Anna Laura [1 ]
Giovannini, Marco [2 ,3 ]
Papi, Laura [1 ]
机构
[1] Univ Florence, Dept Expt & Clin Biomed Sci Mario Serio, Med Genet Unit, Florence, Italy
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, JCCC, Los Angeles, CA 90095 USA
关键词
Neurofibromatosis type 2; Schwannomatosis; NF2; SMARCB1; RHABDOID TUMORS; NEUROFIBROMATOSIS TYPE-2; GENE; INI1; INI1/SMARCB1; MENINGIOMAS; SUPPRESSOR; PHENOTYPE; DELETIONS;
D O I
10.1007/s11060-017-2711-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In sporadic schwannomas, inactivation of both copies of the NF2 tumor suppressor gene on 22q is common. Constitutional mutations of SMARCB1 are responsible of schwannomatosis, an inherited tumor predisposition syndrome, characterized by the development of multiple schwannomas. We analysed the frequency of copy number changes on chromosome 22 and the mutation of NF2 and SMARCB1 in 26 sporadic schwannomas. We found two spinal schwannomas with an identical somatic missense mutation in SMARCB1 exon 9: p.(Arg377His). Both SMARCB1 mutated schwannomas had LOH of 22q and one of them harbored an inactivating mutation of NF2. The p.(Arg377His) change was not found in a series of 28 vestibular schwannomas. Our data indicate that mutations affecting SMARCB1 play a role in the development or progression of a small subset of spinal schwannomas and that biallelic inactivation of SMARCB1 may cooperate with deficiency of NF2 function in schwannoma tumorigenesis according to the "four-hit/three events" mechanism of tumorigenesis that we demonstrated in schwannomatosis-associated schwannomas.
引用
收藏
页码:33 / 38
页数:6
相关论文
共 50 条
[31]   Alternative outcomes of pathogenic complex somatic structural variations in the genomes of NF1 and NF2 patients [J].
Hsiao, Meng-Chang ;
Piotrowski, Arkadiusz ;
Poplawski, Andrzej Brunon ;
Callens, Tom ;
Fu, Chuanhua ;
Messiaen, Ludwine .
NEUROGENETICS, 2017, 18 (03) :169-174
[32]   Immunohistochemical analysis supports a role for INI1/SMARCB1 in hereditary forms of schwannomas, but not in solitary, sporadic schwannomas [J].
Patil, Sushama ;
Perry, Arie ;
MacCollin, Mia ;
Dong, Shumin ;
Betensky, Rebecca A. ;
Yeh, Tu-Hsueh ;
Gutmann, David H. ;
Stemmer-Rachamimov, Anat O. .
BRAIN PATHOLOGY, 2008, 18 (04) :517-519
[33]   NF2 Genetic Alterations in Sporadic Vestibular Schwannomas: Clinical Implications [J].
Lassaletta, Luis ;
Torres-Martin, Miguel ;
Pena-Granero, Carolina ;
Maria Roda, Jose ;
Santa-Cruz-Ruiz, Santiago ;
Castresana, Javier S. ;
Gavilan, Javier ;
Rey, Juan A. .
OTOLOGY & NEUROTOLOGY, 2013, 34 (07) :1355-1361
[34]   Loss of NF2/Merlin expression in advanced sporadic colorectal cancer [J].
Cacev, Tamara ;
Aralica, Gorana ;
Loncar, Bozo ;
Kapitanovic, Sanja .
CELLULAR ONCOLOGY, 2014, 37 (01) :69-77
[35]   Six novel mutations in the NF2 tumor suppressor gene [J].
Leone, PE ;
Bello, MJ ;
Mendiola, M ;
Vaquero, J ;
Sarasa, JL ;
Kusak, ME ;
De Campos, JM ;
Pestana, A ;
Rey, JA .
INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 12 (04) :935-938
[36]   Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations [J].
Brastianos, Priscilla K. ;
Twohy, Erin L. ;
Gerstner, Elizabeth R. ;
Kaufmann, Timothy J. ;
Iafrate, John ;
Lennerz, Jochen ;
Jeyapalan, Suriya ;
Piccioni, David E. ;
Monga, Varun ;
Fadul, Camilo E. ;
Schiff, David ;
Taylor, Jennie W. ;
Chowdhary, Sajeel A. ;
Bettegowda, Chetan ;
Ansstas, George ;
de la Fuente, Macarena ;
Anderson, Mark D. ;
Shonka, Nicole ;
Damek, Denise ;
Carrillo, Jose ;
Kunschner-Ronan, Lara J. ;
Chaudhary, Rekha ;
Jaeckle, Kurt A. ;
Senecal, Francis M. ;
Kaley, Thomas ;
Morrison, Tara ;
Thomas, Alissa A. ;
Welch, Mary R. ;
Iwamoto, Fabio ;
Cachia, David ;
Cohen, Adam L. ;
Vora, Shivangi ;
Knopp, Michael ;
Dunn, Ian F. ;
Kumthekar, Priya ;
Sarkaria, Jann ;
Geyer, Susan ;
Carrero, Xiomara W. ;
Martinez-Lage, Maria ;
Cahill, Daniel P. ;
Brown, Paul D. ;
Giannini, Caterina ;
Santagata, Sandro ;
Barker, Frederick G. ;
Galanis, Evanthia .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (03) :618-+
[37]   Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas [J].
Hadfield, K. D. ;
Smith, M. J. ;
Urquhart, J. E. ;
Wallace, A. J. ;
Bowers, N. L. ;
King, A. T. ;
Rutherford, S. A. ;
Trump, D. ;
Newman, W. G. ;
Evans, D. G. .
ONCOGENE, 2010, 29 (47) :6216-6221
[38]   Somatic Mosaicism of NF2 Gene Mutation with Constitutional NF1 Gene Mutation in Neurofibromatosis Type 2: a Case Report [J].
Yoo, Soo Jin ;
Hwang, Yong-Soon .
CLINICAL LABORATORY, 2020, 66 (11) :2375-2378
[39]   Neurofibromatosis: A Review of NF1, NF2, and Schwannomatosis [J].
Kresak, Jesse Lee ;
Walsh, Meggen .
JOURNAL OF PEDIATRIC GENETICS, 2016, 5 (02) :98-104
[40]   The Prognostic Value of Methylation Signatures and NF2 Mutations in Atypical Meningiomas [J].
Meta, Rahmina ;
Boldt, Henning B. ;
Kristensen, Bjarne W. ;
Sahm, Felix ;
Sjursen, Wenche ;
Torp, Sverre H. .
CANCERS, 2021, 13 (06) :1-13